SC
AEMD icon

Shay Capital’s Aethlon Medical AEMD Stock Holding History

Shay Capital’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6K Buy
6,214
+3,389
+120% +$35.1K ﹤0.01% 477
2026
Q1 		$30.9K Buy
+2,825
New +$32.1K ﹤0.01% 461

Other funds holding AEMD

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Shay Capital's AEMD Position: Q2 2026 in Review

Shay Capital increased its Aethlon Medical (AEMD) stake by 120% in Q2 2026, buying an estimated $35.1K and bringing the position to 6,214 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Shay Capital first reported a position in AEMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $30.9K in Q1 2026. 16 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

  • Shay Capital held 6,214 shares of Aethlon Medical worth $25.6K as of Q2 2026.
  • Shay Capital bought 3,389 Aethlon Medical shares in Q2 2026, an estimated $35.1K.
  • Aethlon Medical made up ﹤0.01% of Shay Capital's portfolio in Q2 2026, its #477 holding.
  • Shay Capital first reported a position in Aethlon Medical in Q1 2026 and has held it in 2 quarters since.
  • Shay Capital's Aethlon Medical position peaked at $30.9K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.